In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression

April 1, 2010

Bibliographic Details
Main Authors: Ho, Emily E., Dubrovsky, Esther, Gertler, Frank, Meacham, Corbin Elizabeth, Hemann, Michael
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: Nature Publishing Group 2012
Online Access:http://hdl.handle.net/1721.1/73630
https://orcid.org/0000-0003-3214-4554
_version_ 1811078707598589952
author Ho, Emily E.
Dubrovsky, Esther
Gertler, Frank
Meacham, Corbin Elizabeth
Hemann, Michael
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Ho, Emily E.
Dubrovsky, Esther
Gertler, Frank
Meacham, Corbin Elizabeth
Hemann, Michael
author_sort Ho, Emily E.
collection MIT
description April 1, 2010
first_indexed 2024-09-23T11:04:11Z
format Article
id mit-1721.1/73630
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:04:11Z
publishDate 2012
publisher Nature Publishing Group
record_format dspace
spelling mit-1721.1/736302022-10-01T00:57:16Z In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression Ho, Emily E. Dubrovsky, Esther Gertler, Frank Meacham, Corbin Elizabeth Hemann, Michael Massachusetts Institute of Technology. Department of Biology Koch Institute for Integrative Cancer Research at MIT Ho, Emily E. Dubrovsky, Esther Gertler, Frank Meacham, Corbin Elizabeth Hemann, Michael April 1, 2010 Mouse models have markedly improved our understanding of cancer development and tumor biology. However, these models have shown limited efficacy as tractable systems for unbiased genetic experimentation. Here, we report the adaptation of loss-of-function screening to mouse models of cancer. Specifically, we have been able to introduce a library of shRNAs into individual mice using transplantable Eμ-myc lymphoma cells. This approach has allowed us to screen nearly 1,000 genetic alterations in the context of a single tumor-bearing mouse. These experiments have identified a central role for regulators of actin dynamics and cell motility in lymphoma cell homeostasis in vivo. Validation experiments confirmed that these proteins represent bona fide lymphoma drug targets. Additionally, suppression of two of these targets, Rac2 and twinfilin, potentiated the action of the front-line chemotherapeutic vincristine, suggesting a critical relationship between cell motility and tumor relapse in hematopoietic malignancies. National Institutes of Health (U.S.) (RO1 CA128803-01) Massachusetts Institute of Technology. Dept. of Biology (Training Grant) Massachusetts Institute of Technology. Undergraduate Research Opportunities Program National Cancer Institute (U.S.). Integrative Cancer Biology Program (Grant 1-U54-CA112967) 2012-10-04T20:30:51Z 2012-10-04T20:30:51Z 2009-09 2009-01 Article http://purl.org/eprint/type/JournalArticle 1061-4036 1546-1718 http://hdl.handle.net/1721.1/73630 Meacham, Corbin E. et al. “In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression.” Nature Genetics 41.10 (2009): 1133–1137. https://orcid.org/0000-0003-3214-4554 en_US http://dx.doi.org/10.1038/ng.451 Nature Genetics Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/ application/pdf Nature Publishing Group PMC
spellingShingle Ho, Emily E.
Dubrovsky, Esther
Gertler, Frank
Meacham, Corbin Elizabeth
Hemann, Michael
In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title_full In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title_fullStr In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title_full_unstemmed In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title_short In Vivo RNAi Screening Identifies Regulators of Actin Dynamics as Key Determinants of Lymphoma Progression
title_sort in vivo rnai screening identifies regulators of actin dynamics as key determinants of lymphoma progression
url http://hdl.handle.net/1721.1/73630
https://orcid.org/0000-0003-3214-4554
work_keys_str_mv AT hoemilye invivornaiscreeningidentifiesregulatorsofactindynamicsaskeydeterminantsoflymphomaprogression
AT dubrovskyesther invivornaiscreeningidentifiesregulatorsofactindynamicsaskeydeterminantsoflymphomaprogression
AT gertlerfrank invivornaiscreeningidentifiesregulatorsofactindynamicsaskeydeterminantsoflymphomaprogression
AT meachamcorbinelizabeth invivornaiscreeningidentifiesregulatorsofactindynamicsaskeydeterminantsoflymphomaprogression
AT hemannmichael invivornaiscreeningidentifiesregulatorsofactindynamicsaskeydeterminantsoflymphomaprogression